Loading...
The "AI-Immunology" Asymmetric Opportunity – Validated by Merck (MSD)
n/a
n/a
Talos's Fair Value
n/a
1Y
-28.4%7D
-9.4%1Y
-28.4%7D
-9.4%You can edit this narrative until Dec 3 10:35 AM. Then, changes will post as Updates.
You can edit this narrative until Dec 3 10:35 AM. Then, changes will post as Updates.